Reach Us +1-217-403-9671
Self-nanoemulsifying Drug Delivery System Of Amisulpride: Optimization Of Formulation Variables Using Central Composite Design | 8217
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Self-nanoemulsifying drug delivery system of Amisulpride: Optimization of formulation variables using central composite design

2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit-2011 and International Conference on Pharmaceutics & Novel Drug Delivery Systems

Ahmed A. Aboelwafa and Amal Ibrahim

ScientificTracks Abstracts: JBB

DOI: 10.4172/2153-2435.10000S4

A misulpride is practically insoluble in water and suff ers from irregular and low bioavailability (48%). It is metabolized in liver to minor degree. Accordingly, this irregular and low bioavailability could be due to low solubility and P-glycoprotein effl ux which also aff ect its penetration through blood brain barrier. In the current study, in an attempt to solve these problems, Amisulpride self-nanoemulsifying drug delivery systems (SNEDDS) were prepared. Preliminary screening was carried out to determine Amisulpride solubility in various oils and surfactants. Th e formulations were prepared using oil (Caproyl-90), two surfactants (Cremophor EL and Labrasol, ?Smix?) and cosurfactant (Transcutol HP). Response surface methodology based on central composite design was applied for formulation optimization. Oil percentage, Smix: cosurfactant ratio and Cremophor EL: Labrasol ratio in Smix were selected as independent variables while mean droplet sizes at pH 1.2, 4.5 and 6.8, drug loading and absorbance of diluted SNEDDS at pH 1.2, 4.5 and 6.8 as dependent variables. A second-order polynomial equations were fi tted to data. Optimized formulation, containing 10% oil, 1.31 Smix: cosurfactant ratio and 2 ratio of Cremophor EL: Labrasol was prepared according to soft ware determined levels using desirability function and overlay plot. It provided a drug loading of 50.2 mg/ml and mean droplet sizes of 28, 120 and 95 nm in pH 1.2, 4.5 and 6.8 respectively. Also, it released Amisulpride completely within 15 min irrespective of the type or pH of dissolution medium. Bearing in mind that optimized SNEDDS incorporates bioactive ingredients, it could be potential for improving Amisulpride oral bioavailability